Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Therma Bright Inc V.THRM

Alternate Symbol(s):  TBRIF

Therma Bright Inc. is a Canada-based company, which is a developer and partner in a range of diagnostic and medical device technologies. It focuses on providing consumers and medical professionals with solutions that address medical and healthcare challenges. It is involved in developing, acquiring, manufacturing, and marketing proprietary healthcare and medical devices for the consumer and institutional marketplace. Its product offerings include Covid-19 diagnostic test product line, such as AcuVid COVID-19 Rapid Antigen Saliva Test and AcuVid COVID-19 Rapid Antibody Test; Sores & Bite Inflammation Therapy product line, such as InterceptCS Cold Sore Prevention System and TherOZap, and Muscle Pain & Blood Circulation Health Therapy product line, such as Venowave, which is a circulation booster designed to improve circulation in the lower extremities. Its products include Benepod, Inretio, AI4LYF, Invixa and Instatin, and others.


TSXV:THRM - Post by User

Post by Zimmee1on Sep 17, 2021 9:01am
215 Views
Post# 33876531

NVCN has received yesterday her FDA approval and who's next?

NVCN has received yesterday her FDA approval and who's next?

Recent Bulletins News ReleasesIn The NewsOther
Date ET Symbol Price Type Headline
2021-09-16 09:30 C:NVCN 0.93 News Release Neovasc receives FDA approval for Cosira-II trial

 

Recent Trades - All 0 today
 

 

 

 

 

 

 

08:55:10 EDT Fri 17 Sep 2021
T:NVCN - NEOVASC INC - https://www.neovasc.com 08:55:10 EDT
Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr Open-Hi-Lo Year Hi-Lo Last Tr News Delay
NVCN - T   17.0 0.95 · 1.05 4.0 0.95                3.48  0.86 Sep 16 Sep 16 15 min RT 2¢
TSX - T 17.0 0.95 · 1.05 4.0 0.95                3.48  0.86 Sep 16   15 min

<< Previous
Bullboard Posts
Next >>